Prostate cancer is now the most common cancer in the UK, according to new analysis - as a leading charity renewed its calls for a national screening program. NHS data found 55,033 men were ...

Jan. 28, 2025 — The inherited mutated gene WNT9B, which functions normally in embryonic prostate development, increases risk of adult prostate cancer, according to a new ... Jan. 3, 2025 — In ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research ...

Jan. 15, 2025 – Prostate cancer is quite common – over 60% of those diagnosed are men over the age of 65 – but it’s not a high priority for cancer researchers. One big reason ...

Over the past 14 years, clinicians have seen rapid growth in their therapeutic armamentarium to treat advanced prostate cancer. They can now choose among 4 novel second-generation hormone ...

Prostate cancer is the most common cancer for men in the UK, with one in eight diagnosed with the disease in their lifetime. The process uses existing ultrasound equipment which is widely ...

Shares of PFM were trading flat on the day. Components of that ETF with the highest volume on Wednesday were Apple, trading down about 0.7% with over 20.9 million shares changing hands so far this ...

Prostate Cancer and Prostatic Diseases covers all aspects of prostatic diseases, in particular prostate cancer, the subject of intensive basic and clinical research world-wide. The journal also ...

During its investment period, PFM and Roynat worked closely with All-Fab to reportedly achieve growth and operational milestones. REGINA — PFM Capital Inc. announces that they, together with ...

“The key here is I don’t believe that testosterone increases the risk of prostate cancer progression or biochemical recurrence," says Mohit Khera, MD, MBA, MPH. Overall, 39% of those who received a ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and ...

Allen is professor of clinical psychology at the University of Oregon and the CEO and co-founder of Ksana Health. Although the Biden-Harris administration is coming to an end, some of its work ...